Black Rock Inc. Collegium Pharmaceutical, Inc Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding COLL
# of Institutions
246Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.9 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$68.5 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$66.5 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$62.4 Million0.15% of portfolio
-
Invesco Ltd. Atlanta, GA1.78MShares$51.7 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $994M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...